Invivyd Inc (NAS:IVVD)
$ 0.9505 -0.0101 (-1.05%) Market Cap: 113.53 Mil Enterprise Value: -33.67 Mil PE Ratio: 0 PB Ratio: 0.81 GF Score: 29/100

Invivyd Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 04:55PM GMT
Release Date Price: $1.76 (-6.88%)
Maxwell Skor

Great. Hello, everyone. I'm Maxwell Skor, biotech analysts with Morgan Stanley. And before we get started, I need to read an important disclosure.

Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures.

And with that, I would like to welcome Dave Hering, CEO of Invivyd. Welcome to the conference.

David Hering
Invivyd, Inc. - CEO & Director

Thank you.

Questions & Answers

Maxwell Skor

Thank you. And for those in the audience who are either new to or revisiting the in Invivyd story, I was hoping we kind of discuss COVID in general, the current status of the pandemic, and then we can dive into the programs, if that's all right.

David Hering
Invivyd, Inc. - CEO & Director

Yes. I mean, thankfully, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot